Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation

Completed · Phase 4

Conditions studied: Acne Vulgaris

In brief

The purpose of this study is to evaluate the safety and efficacy of trifarotene 50 microgram per gram (mcg/g) cream compared to its vehicle on the risk of formation of atrophic acne scars after 24 weeks of treatment in facial acne participants assessed by atrophic acne scars count.

Key facts

Study ID
NCT04856904
Run by
Galderma R&D
People needed
121
Starts
2021-05-28
Expected to finish
2023-06-30
Last updated by the study team
2024-06-11

Who can join

Age: 17 and older, up to 35. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.